Cargando…
Author Correction: Methylprednisolone stimulated gene expression (GILZ, MCL-1) and basal cortisol levels in multiple sclerosis patients in relapse are associated with clinical response
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604895/ https://www.ncbi.nlm.nih.gov/pubmed/34799697 http://dx.doi.org/10.1038/s41598-021-02415-8 |
_version_ | 1784602056716189696 |
---|---|
author | Evangelopoulos, Maria Eleftheria Nasiri‑Ansari, Narjes Kassi, Eva Papadopoulou, Anna Evangelopoulos, Dimitrios Stergios Moutsatsou, Paraskevi |
author_facet | Evangelopoulos, Maria Eleftheria Nasiri‑Ansari, Narjes Kassi, Eva Papadopoulou, Anna Evangelopoulos, Dimitrios Stergios Moutsatsou, Paraskevi |
author_sort | Evangelopoulos, Maria Eleftheria |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8604895 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-86048952021-11-22 Author Correction: Methylprednisolone stimulated gene expression (GILZ, MCL-1) and basal cortisol levels in multiple sclerosis patients in relapse are associated with clinical response Evangelopoulos, Maria Eleftheria Nasiri‑Ansari, Narjes Kassi, Eva Papadopoulou, Anna Evangelopoulos, Dimitrios Stergios Moutsatsou, Paraskevi Sci Rep Author Correction Nature Publishing Group UK 2021-11-19 /pmc/articles/PMC8604895/ /pubmed/34799697 http://dx.doi.org/10.1038/s41598-021-02415-8 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Author Correction Evangelopoulos, Maria Eleftheria Nasiri‑Ansari, Narjes Kassi, Eva Papadopoulou, Anna Evangelopoulos, Dimitrios Stergios Moutsatsou, Paraskevi Author Correction: Methylprednisolone stimulated gene expression (GILZ, MCL-1) and basal cortisol levels in multiple sclerosis patients in relapse are associated with clinical response |
title | Author Correction: Methylprednisolone stimulated gene expression (GILZ, MCL-1) and basal cortisol levels in multiple sclerosis patients in relapse are associated with clinical response |
title_full | Author Correction: Methylprednisolone stimulated gene expression (GILZ, MCL-1) and basal cortisol levels in multiple sclerosis patients in relapse are associated with clinical response |
title_fullStr | Author Correction: Methylprednisolone stimulated gene expression (GILZ, MCL-1) and basal cortisol levels in multiple sclerosis patients in relapse are associated with clinical response |
title_full_unstemmed | Author Correction: Methylprednisolone stimulated gene expression (GILZ, MCL-1) and basal cortisol levels in multiple sclerosis patients in relapse are associated with clinical response |
title_short | Author Correction: Methylprednisolone stimulated gene expression (GILZ, MCL-1) and basal cortisol levels in multiple sclerosis patients in relapse are associated with clinical response |
title_sort | author correction: methylprednisolone stimulated gene expression (gilz, mcl-1) and basal cortisol levels in multiple sclerosis patients in relapse are associated with clinical response |
topic | Author Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604895/ https://www.ncbi.nlm.nih.gov/pubmed/34799697 http://dx.doi.org/10.1038/s41598-021-02415-8 |
work_keys_str_mv | AT evangelopoulosmariaeleftheria authorcorrectionmethylprednisolonestimulatedgeneexpressiongilzmcl1andbasalcortisollevelsinmultiplesclerosispatientsinrelapseareassociatedwithclinicalresponse AT nasiriansarinarjes authorcorrectionmethylprednisolonestimulatedgeneexpressiongilzmcl1andbasalcortisollevelsinmultiplesclerosispatientsinrelapseareassociatedwithclinicalresponse AT kassieva authorcorrectionmethylprednisolonestimulatedgeneexpressiongilzmcl1andbasalcortisollevelsinmultiplesclerosispatientsinrelapseareassociatedwithclinicalresponse AT papadopoulouanna authorcorrectionmethylprednisolonestimulatedgeneexpressiongilzmcl1andbasalcortisollevelsinmultiplesclerosispatientsinrelapseareassociatedwithclinicalresponse AT evangelopoulosdimitriosstergios authorcorrectionmethylprednisolonestimulatedgeneexpressiongilzmcl1andbasalcortisollevelsinmultiplesclerosispatientsinrelapseareassociatedwithclinicalresponse AT moutsatsouparaskevi authorcorrectionmethylprednisolonestimulatedgeneexpressiongilzmcl1andbasalcortisollevelsinmultiplesclerosispatientsinrelapseareassociatedwithclinicalresponse |